The increase in the number of individuals susceptible to macular degeneration is expected to help the market capture maximum shares in the coming years. About 11 million people in the U.S. have some form of age-related macular degeneration, according to the Bright Focus Foundation. Additionally, this number will double to nearly 22 million by 2050, depending on growth rates.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.alliedmarketresearch.com/request-sample/11581
Moreover, the total number of people living with macular degeneration is projected to increase to 196 million worldwide by 2020 and to about 288 million by 2040. The foundation also notes that age is a major risk factor for age-related macular degeneration. The risk of developing advanced age-related macular degeneration increases from 2% for people aged 50-59 to approximately 30% for people over the age of 75.
COVID-19 Scenario Analysis
Pharmaceutical and biotechnological companies have joined hands with governments around the globe to combat with the COVID-19 outbreak, for assisting in the development of various vaccines to ensure appropriate alternatives for medicines supply chain challenges. The estimates suggest that there are about 115 vaccine candidates and about 155 molecules, which are in the R&D pipeline. Due to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is hence anticipated to witness a significant growth for the newly developed drugs for the managements of the COVID-19 in the future. The current scenario has brought halt in the massive production of the medications used for macular degeneration treatment and also has broadly affected the supply of the medications, which is probing challenges for the major market players. However, the growing concern to lead healthy life has emerged due to the pandemic and hence, would propel the growth of this industry in the coming years.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ@ https://www.alliedmarketresearch.com/purchase-enquiry/11581
๐๐๐ฒ ๐ ๐ข๐ง๐๐ข๐ง๐ ๐ฌ
- This study presents the analytical depiction of the global macular degeneration treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global macular degeneration treatment market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Macular Degeneration Treatment market growth scenario.
- Porterโs five forces analysis illustrates the potency of buyers & suppliers in the macular degeneration treatment market.
- The report provides a detailed global macular degeneration treatment market analysis based on competitive intensity and how the competition will take shape in coming years.
๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐๐ช๐ฎ๐๐ฌ๐ญ@ https://www.alliedmarketresearch.com/request-for-customization/11581
๐๐๐๐๐ข๐ง๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
The key players profiled in this report include Novartis AG, F. Hoffmann-La Roche AG, Bausch Health Companies Inc., Regeneron, Ellex, REGENXBIO Inc., Aerie Pharmaceutical Inc., Panoptica, and Pfizer Inc.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
๐๐ ๐๐ฅ๐ฌ๐จ ๐๐๐๐๐ซ๐ฌ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
- North America Macular Degeneration Treatment Market
- Japan Macular Degeneration Treatment Market
- South Korea Macular Degeneration Treatment Market
- Singapore Macular Degeneration Treatment Market
- Australia Macular Degeneration Treatment Market
- Europe Macular Degeneration Treatment Market
- China Macular Degeneration Treatment Market
- Taiwan Macular Degeneration Treatment Market
- New Zealand Macular Degeneration Treatment Market
๐๐๐ฅ๐๐ญ๐๐ ๐๐ฅ๐จ๐ :
- Deep Brain Stimulation Equipment Market Grows With Rising Neurological Disorders In South Korea: https://southkoreahealthcarepress.blogspot.com/2022/05/deep-brain-stimulation-equipment-market.html
- Demand for Plasma Fractionation Has Highly Increased across Vietnam: https://southkoreahealthcarepress.blogspot.com/2022/03/demand-for-plasma-fractionation-has.html
- Heparin Market Analysis in South Korea Region: Role of Heparin Drugs in Medicine: https://southkoreahealthcarepress.blogspot.com/2022/04/heparin-market-analysis-in-south-korea.html
- COVID-19 Impact on Workplace Wellness Market In South Korea Region: https://southkoreahealthcarepress.blogspot.com/2022/05/covid-19-impact-on-workplace-wellness.html
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com